Featured Article
- Pet Grooming Industry Transforming Companion Animal Wellness
Cover Story
- Merck Animal Health to Acquire TARGAN
Research & Innovation
- VetrixBio Unveils First Clinical Data for VTX-304
- Pelara Launches Veterinary Clinical Trials
Financing & Partnerships
- Rejuvenate Bio Secures Financing and Partners with Merck Animal Health
- VEG Partners with VetRec on AI Documentation
Product Launches
- Cronus Pharma Launches First FDA-Approved Bioequivalent of Vetmedin
Mergers & Acquisitions
- Alivira Expands European Companion Animal Footprint
- Ceva Strengthens Swine Health Portfolio
Regulatory Updates
- FDA Authorizes First Generic Treatment for New World Screwworm
At a Glance
- Merck Animal Health expands poultry automation capabilities through TARGAN acquisition
- VetrixBio reports promising dual-action osteoarthritis data with VTX-304
- Rejuvenate Bio and Merck Animal Health advance veterinary gene therapy collaboration
- Cronus Pharma launches first FDA-approved Vetmedin bioequivalent
- Alivira strengthens European companion animal presence with BioForLife acquisition
- Ceva adds Europe’s first swine dysentery vaccine through Aquilón acquisition
- VEG adopts AI-powered documentation across veterinary emergency hospitals
- Pelara begins clinical evaluation of ultrasound-based chronic pain management
- FDA authorizes first generic treatment for New World screwworm infestations
Merck Animal Health Expands Poultry Tech Portfolio
Acquisition
Merck Animal Health has agreed to acquire TARGAN, adding advanced poultry automation and biodevice technology to its portfolio.
Key highlights
- TARGAN develops automated biodevice solutions for commercial poultry operations.
- WingScan can process up to 160,000 chicks per hour for automated chick-sexing.
- The company also offers high-speed ocular spray technology for vaccine delivery in day-old chicks.
- The transaction is expected to close in Q3 2026, subject to regulatory approvals.
Impact:
The acquisition strengthens Merck Animal Health’s poultry capabilities and expands its access to precision automation and vaccine delivery technologies. The deal supports more efficient hatchery operations, improved vaccination programs, and broader adoption of advanced poultry production technologies.
The Evolution of Modern Pet Grooming
Pet grooming has evolved far beyond aesthetics and hygiene to become an essential component of companion animal health and wellness. As pet ownership continues to rise globally and humanization trends strengthen the bond between pet owners and their animals, demand for professional grooming services is experiencing significant growth. Modern grooming practices now play an important role in preventive healthcare by supporting skin health, early disease detection, parasite control, and overall well-being. The pet grooming industry is increasingly becoming a critical segment of the broader companion animal care ecosystem, helping veterinarians and pet owners maintain healthier and happier pets.
One of the primary drivers of growth in the pet grooming industry is the increasing awareness of preventive pet care. Regular grooming sessions allow trained professionals to identify early signs of skin disorders, ear infections, dental issues, lumps, parasites, and other abnormalities that may otherwise go unnoticed. Early detection of potential health concerns enables pet owners to seek veterinary attention promptly, contributing to improved health outcomes and reducing the risk of more serious medical complications. As preventive care becomes a priority among pet owners, grooming services are gaining recognition as valuable contributors to routine health maintenance.
Technological advancements are also reshaping the pet grooming landscape. Modern grooming facilities are adopting specialized equipment designed to improve safety, efficiency, and comfort for companion animals. Advanced drying systems, ergonomic grooming tools, low-stress handling equipment, and skin-friendly bathing technologies are helping groomers provide higher-quality services while minimizing anxiety and discomfort. These innovations support improved grooming experiences for pets and enable professionals to address the diverse needs of different breeds, coat types, and health conditions.
Mobile pet grooming services are emerging as a rapidly expanding segment within the industry. Mobile grooming units offer convenience by providing personalized services directly at the pet owner’s location. This approach reduces transportation-related stress for animals, particularly senior pets, anxious companions, and those with mobility limitations. Mobile services also allow groomers to deliver individualized attention in a controlled environment, enhancing both customer satisfaction and animal welfare. As convenience-driven consumer preferences continue to influence purchasing decisions, mobile grooming is expected to remain a key growth area within the market.
Premiumization is another significant trend shaping the pet grooming industry. Pet owners are increasingly seeking specialized grooming treatments that extend beyond basic bathing and hair trimming. Services such as breed-specific styling, spa treatments, skin conditioning therapies, aromatherapy, paw care, and coat restoration programs are gaining popularity. These premium offerings reflect the growing willingness of pet owners to invest in high-quality care experiences that promote comfort, wellness, and appearance. The expansion of luxury grooming services is creating new revenue opportunities for grooming businesses while elevating industry standards.
Digital technologies are further transforming customer engagement and operational efficiency within the grooming sector. Online appointment scheduling platforms, mobile applications, customer relationship management systems, and digital health records are streamlining service delivery and improving communication between groomers and pet owners. Many businesses are also utilizing social media platforms to showcase grooming results, educate pet owners, and strengthen brand visibility. These digital tools support business growth while enhancing convenience and transparency for customers.
Sustainability is becoming an increasingly important consideration across the pet grooming industry. Consumers are showing greater interest in environmentally responsible products and services, encouraging grooming providers to adopt eco-friendly shampoos, biodegradable grooming supplies, water-efficient equipment, and sustainable packaging solutions. Businesses that prioritize sustainability are not only reducing their environmental impact but also aligning with evolving consumer expectations regarding responsible pet care practices.
Workforce development and professional training continue to play vital roles in industry advancement. Grooming professionals are pursuing specialized certifications and educational programs to enhance their skills in breed-specific grooming, animal behavior, safety protocols, and wellness-focused care. Continued investment in training helps improve service quality, supports animal welfare standards, and strengthens consumer confidence in professional grooming providers. As industry expectations evolve, skilled groomers are becoming increasingly important contributors to companion animal health and wellness.
The integration of grooming services with veterinary care is also creating new opportunities for collaborative pet health management. Veterinary clinics and grooming providers are increasingly working together to monitor skin conditions, identify potential health concerns, and support preventive care strategies. This collaborative approach enables more comprehensive monitoring of companion animal health while fostering stronger relationships between pet owners and care providers.
Despite strong growth prospects, the pet grooming industry faces several challenges. Labor shortages, rising operational costs, workforce training requirements, and increasing demand for specialized services can create pressures for grooming businesses. Additionally, maintaining consistent service quality and ensuring animal safety remain ongoing priorities across the industry. Addressing these challenges will be essential to sustaining long-term growth and meeting the evolving expectations of pet owners.
In conclusion, the pet grooming industry is becoming an increasingly important pillar of companion animal care. Advances in grooming technologies, mobile services, premium wellness offerings, digital engagement tools, sustainability initiatives, and professional training are reshaping the industry and expanding its role in preventive healthcare. As pet owners continue to prioritize the health, comfort, and well-being of their companion animals, grooming services will play an increasingly significant role in supporting overall wellness. Through continued innovation, education, and collaboration with veterinary professionals, the pet grooming industry is well-positioned to contribute to the future of companion animal healthcare.
Research update
VetrixBio has presented first clinical data for VTX-304, a dual-action antibody designed to address both pain and cartilage degeneration in canine osteoarthritis.
Key highlights
- Presented at the 6th International Veterinary Pain Short Course at NC State College of Veterinary Medicine.
- Targets both nerve growth factor (NGF) and ADAMTS-5.
- In aged Beagles, a single subcutaneous dose produced pain relief comparable to bedinvetmab.
- Lab studies showed inhibition of NGF/TrkA signaling and ADAMTS-5-mediated aggrecan cleavage.
Impact:
VTX-304 is being developed as a potential disease-modifying osteoarthritis therapy that combines pain control with cartilage protection in one molecule. The data suggest a possible new approach to canine OA treatment that could go beyond symptom relief to address the underlying joint disease process.
Financing / partnership
Rejuvenate Bio has secured $6 million in financing and entered a strategic R&D collaboration with Merck Animal Health to advance veterinary gene therapies.
Key highlights
- Financing round was led by VCapital, with participation from Kendall Capital Partners, Connecticut Innovations, Digitalis, and Merck Animal Health.
- Funds will support development of Rejuvenate Bio’s gene therapy platform and pipeline for companion animals.
- Collaboration with Merck Animal Health will focus on a novel animal health gene therapy program.
- Program details were not disclosed.
Impact:
The partnership underscores growing interest in gene therapy, longevity science, and precision biologics for chronic and age-related diseases in pets. The deal signals rising confidence that advanced genetic medicine could become an important part of future veterinary care, especially for conditions with limited long-term treatment options.
Product launch
Cronus Pharma has launched Pimobendan Chewable Tablets, the first FDA-approved bioequivalent to Vetmedin for managing congestive heart failure in dogs.
Key highlights
- Available in 1.25 mg, 2.5 mg, 5 mg, and 10 mg half-scored chewable tablets.
- Indicated for mild, moderate, and severe congestive heart failure in dogs.
- Approved under FDA ANADA #200-728 as a bioequivalent to Vetmedin.
- Designed to expand access to a widely used therapy in canine cardiology.
Impact:
Pimobendan is a cornerstone treatment for dogs with heart failure associated with myxomatous mitral valve disease and dilated cardiomyopathy. The launch gives veterinarians a regulatory-reviewed alternative to compounded products and may improve access to essential long-term cardiac care.
Acquisition
Viyash Scientific’s Alivira Animal Health has agreed to acquire Italy’s BioForLife to strengthen its position in the European companion animal market.
Key highlights
- Acquisition of 100% of BioForLife Italia for approximately $19.7M.
- Expected to close in Q2 FY27.
- BioForLife reaches more than 80% of veterinary clinics in Italy.
- Portfolio includes nutritional supplements, veterinary pharmaceuticals, and rapid diagnostic tests.
- Expands into dermatology and ophthalmology.
Impact:
The deal gives Alivira an established commercial platform in Italy and creates opportunities to expand products across Europe, the Middle East, Asia, and Latin America. The acquisition strengthens Alivira’s global companion animal strategy and adds a foothold in one of Europe’s fastest-growing pet healthcare markets.
Acquisition
Ceva Animal Health has acquired Aquilón CyL, adding a leading swine health biotech and the first commercially available European vaccine against swine dysentery.
Key highlights
- Aquilón specializes in swine health research, diagnostics, and biological disease prevention.
- Adds the first and only commercially available vaccine in Europe for swine dysentery caused by Brachyspira hyodysenteriae.
- Aquilón’s scientific team will join Ceva.
- Strengthens Ceva’s intestinal health and preventive disease portfolio.
Impact:
The deal expands Ceva’s capabilities in swine vaccine development, diagnostics, and antibiotic-sparing disease management. Swine dysentery is a major production and welfare challenge, and the acquisition gives Ceva a stronger platform for preventive solutions in a high-need segment.
Partnership
VEG ER for Pets has partnered with VetRec to roll out AI-powered medical documentation tools across its emergency veterinary hospital network.
Key highlights
- Built on a six-month pilot program.
- VetRec is now active in more than 70% of VEG hospitals.
- More than 100,000 patient visits were documented during the pilot.
- Designed to reduce recordkeeping burden and improve workflow efficiency in emergency settings.
Impact:
The system is intended to help clinician complete notes faster while maintaining documentation quality and allowing more focus on patient care. AI documentation tools are becoming a practical way to ease administrative pressure in high-volume emergency veterinary medicine.
Clinical trial
Pelara has started its first veterinary clinical trials for Low-Intensity Focused Ultrasound (LIFU), a non-invasive approach to chronic pain management in animals.
Key highlights
- Initial studies are being conducted with Openwater and SecureDX.
- First targets are dogs, cats, and horses.
- Aims to build species-specific safety, efficacy, and workflow data for veterinary adoption.
- Designed as a drug-free, non-invasive therapy for chronic pain.
Impact:
LIFU uses focused ultrasound energy to target pain pathways and musculoskeletal tissues without surgery, sedation, or systemic drug exposure. Chronic pain is common and often undertreated in animals, and LIFU could add a new non-pharmaceutical option for veterinarians if the trials are successful.
Regulatory authorization
The FDA has issued an Emergency Use Authorization for generic Nitenpyram Tablets, the first generic animal drug authorized to treat New World screwworm infestations in dogs and cats.
Key highlights
- Authorized for dogs and cats at least four weeks old and weighing a minimum of two pounds.
- Available over the counter in 11.4 mg and 57 mg tablet strengths.
- Rapid-acting treatment that eliminates most larvae within hours.
- A second dose is recommended six hours after the first.
Impact:
The product is intended to treat active infestations, but it does not prevent reinfestation and may still require wound management and larval removal. New World screwworm is a serious parasitic threat, and a generic treatment option could improve access and affordability during ongoing containment efforts.
The Next Frontier of Animal Health Innovation
This edition highlights the rapid evolution of animal health, from the growing role of pet grooming in preventive wellness to breakthroughs in gene therapy, AI, and disease management. Merck Animal Health expands its reach through the acquisition of TARGAN and a gene therapy collaboration with Rejuvenate Bio. Key developments include VetrixBio’s dual-action osteoarthritis therapy, Cronus Pharma’s FDA-approved Vetmedin bioequivalent, AI-powered veterinary documentation, innovative pain management technologies, strategic acquisitions, and the FDA’s authorization of the first generic treatment for New World screwworm.
The Pulse of Global Animal Health
Enjoyed this edition? Share it with colleagues, partners, and fellow leaders shaping the future of animal health.
The industry is evolving at remarkable speed—from breakthrough biotech partnerships and regulatory milestones to AI-driven diagnostics and next-generation veterinary innovations. Staying informed isn’t just valuable—it’s essential to staying ahead.
Forward this newsletter, repost it, and help foster a more connected, informed, and forward-thinking global animal health community.
